Home Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i
Article
Licensed
Unlicensed Requires Authentication

Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i

  • Giuseppe Lippi ORCID logo EMAIL logo , Laura Pighi , Elisa Paviati , Davide Demonte , Simone De Nitto , Matteo Gelati , Martina Montagnana , Giorgio Gandini , Brandon M. Henry and Gian Luca Salvagno
Published/Copyright: January 8, 2024

Abstract

Objectives

The current study was designed to evaluate the analytical performance of the new Mindray highly sensitive cardiac troponin I (hs-cTnI) chemiluminescent immunoassay on Mindray CL-1200i, as a thorough validation of novel hs-cTnI methods is required before introduction into clinical practice.

Methods

The evaluation of the analytical performance of this hs-cTnI immunoassay encompassed the calculation of the limit of blank (LOB), limit of detection (LOD), functional sensitivity, imprecision, linearity, 99th percentile upper reference limit (URL) and concordance with another previously validated hs-cTnI chemiluminescent immunoassay.

Results

The LOB and LOD were 0.32 and 0.35 ng/L, whilst the functional sensitivity (expressed as cTnI value with <10 % imprecision), was 0.35 ng/L. The linearity was excellent throughout a wide range of clinically measurable values (r=1.00 between 0.8 and 9,726.9 ng/mL). The intra-assay, inter-assay and total imprecision were 1.1–1.3 %, 5.5–8.1 % and 5.6–8.2 %, respectively. The 99th percentile URL calculated using residual plasma from 246 ostensibly healthy blood donors was 9.2 ng/L (4.3 ng/L in women vs. 12.3 ng/L in men). The Spearman’s correlation between Mindray hs-cTnI and Access hs-TnI was 0.97, with mean bias of 7.2 % (95 % CI, 2.6–11.9 %).

Conclusions

Although we failed to confirm the very optimistic analytical characteristics previously reported for this method, our evaluation of the novel Mindray hs-cTnI immunoassay on CL-1200i demonstrated that the overall performance is comparable to that of other commercially available hs-cTnI techniques, making it a viable alternative to other methods.


Corresponding author: Prof. Giuseppe Lippi, Section of Clinical Biochemistry, University Hospital of Verona, P.le LA Scuro 10, 37134 Verona, Italy, E-mail:
Giuseppe Lippi and Laura Pighi contributed equally to this work.
  1. Research ethics: The study was cleared by the local Institutional Review Board (University Hospital of Verona, Verona, Italy; SOPAV2, protocol number: 971CESC, date of approval: 25 July, 2016).

  2. Informed consent: Not applicable.

  3. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Competing interests: The instrumentation and reagents used in this study were provided by Mindray, but the company played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  5. Research funding: None declared.

  6. Data availability: Data will be available upon reasonable request to the corresponding author.

References

1. Tsao, CW, Aday, AW, Almarzooq, ZI, Anderson, CAM, Arora, P, Avery, CL, et al.. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 2023;147:e93–621. https://doi.org/10.1161/cir.0000000000001123.Search in Google Scholar

2. De Luca, G, Suryapranata, H, Ottervanger, JP, Antman, EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 2004;109:1223–5. https://doi.org/10.1161/01.cir.0000121424.76486.20.Search in Google Scholar PubMed

3. Cervellin, G, Mattiuzzi, C, Bovo, C, Lippi, G. Diagnostic algorithms for acute coronary syndrome-is one better than another? Ann Transl Med 2016;4:193. https://doi.org/10.21037/atm.2016.05.16.Search in Google Scholar PubMed PubMed Central

4. Krintus, M, Panteghini, M. Laboratory-related issues in the measurement of cardiac troponins with highly sensitive assays. Clin Chem Lab Med 2020;58:1773–83. https://doi.org/10.1515/cclm-2020-0017.Search in Google Scholar PubMed

5. Clerico, A, Zaninotto, M, Plebani, M. Rapid rule-in and rule-out protocols of acute myocardial infarction using hs-cTnI and hs-cTnT methods. Clin Chem Lab Med 2023;62:213–7. https://doi.org/10.1515/cclm-2023-1010.Search in Google Scholar PubMed

6. Byrne, RA, Rossello, X, Coughlan, JJ, Barbato, E, Berry, C, Chieffo, A, et al.. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 2023;44:3720–826. https://doi.org/10.1093/eurheartj/ehad191.Search in Google Scholar PubMed

7. Li, L, Shu, X, Zhang, L, Xu, A, Yang, J, Jing, Y, et al.. Evaluation of the analytical and clinical performance of a new high-sensitivity cardiac troponin I assay: hs-cTnI (CLIA) assay. Clin Chem Lab Med 2023;62:353–60. https://doi.org/10.1515/cclm-2023-0529.Search in Google Scholar PubMed

8. Armbruster, DA, Pry, T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008;29(1 Suppl):S49–52.Search in Google Scholar

9. Krouwer, JS, Rabinowitz, R. How to improve estimates of imprecision. Clin Chem 1984;30:290–2. https://doi.org/10.1093/clinchem/30.2.290.Search in Google Scholar

10. Clinical and Laboratory Standards Institute. Defining, establishing, and verifying reference intervals in the clinical laboratory, 3rd ed. Wayne, PA, USA: Document EP28-A3C. CLSI; 2010.Search in Google Scholar

11. Lippi, G, Ferrari, A, Gandini, G, Gelati, M, Lo Cascio, C, Salvagno, GL. Analytical evaluation of the new Beckman Coulter Access high sensitivity cardiac troponin I immunoassay. Clin Chem Lab Med 2017;56:157–61. https://doi.org/10.1515/cclm-2017-0350.Search in Google Scholar PubMed

12. Clerico, A, Zaninotto, M, Passino, C, Padoan, A, Migliardi, M, Plebani, M. High-sensitivity methods for cardiac troponins: the mission is not over yet. Adv Clin Chem 2021;103:215–52. https://doi.org/10.1016/bs.acc.2020.08.009.Search in Google Scholar PubMed

Received: 2023-12-15
Accepted: 2023-12-25
Published Online: 2024-01-08
Published in Print: 2024-06-25

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. LC-MS/MS random access automation – a game changer for the 24/7 clinical laboratory
  4. Reviews
  5. Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges
  6. Differential diagnosis of ascites: etiologies, ascitic fluid analysis, diagnostic algorithm
  7. Opinion Papers
  8. Clinical Decision Support System in laboratory medicine
  9. Blood over-testing: impact, ethical issues and mitigating actions
  10. General Clinical Chemistry and Laboratory Medicine
  11. An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure for the quantification of zonisamide in human serum and plasma
  12. An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure for the quantification of carbamazepine in human serum and plasma
  13. An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of phenobarbital in human serum and plasma
  14. An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of primidone in human serum and plasma
  15. An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure for the quantification of carbamazepine-10,11-epoxide in human serum and plasma
  16. Should we depend on reference intervals from manufacturer package inserts? Comparing TSH and FT4 reference intervals from four manufacturers with results from modern indirect methods and the direct method
  17. Comparison of three chatbots as an assistant for problem-solving in clinical laboratory
  18. Evidence-based cutoffs for total and adjusted calcium: a major factor in detecting severe hypo- and hypercalcemia
  19. Minor head injury in anticoagulated patients: performance of biomarkers S100B, NSE, GFAP, UCH-L1 and Alinity TBI in the detection of intracranial injury. A prospective observational study
  20. A comparative evaluation of the analytical performances of premier resolution-high-performance liquid chromatography (PR-HPLC) with capillary zone electrophoresis (CZE) assays for the detection of hemoglobin variants and the quantitation of HbA0, A2, E, and F
  21. Get reliable laboratory findings – how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?
  22. Reference Values and Biological Variations
  23. Vitamin D and vitamin K status in postmenopausal women with normal and low bone mineral density
  24. Hematology and Coagulation
  25. An automatic analysis and quality assurance method for lymphocyte subset identification
  26. Cancer Diagnostics
  27. Machine learning-based delta check method for detecting misidentification errors in tumor marker tests
  28. Cardiovascular Diseases
  29. Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i
  30. Infectious Diseases
  31. A reactive monocyte subset characterized by low expression of CD91 is expanded during sterile and septic inflammation
  32. Letters to the Editor
  33. Inadvertent omission of a specimen integrity comment – an overlooked post-analytical error
  34. Falsely elevated T3 due to interference of anti-T3 autoantibodies: a case report
  35. Validation of the Siemens Atellica cortisol immunoassay compared to liquid chromatography mass spectrometry in adrenal venous sampling for primary hyperaldosteronism
  36. Lessons learned from site-specific sampling and biological half-life of IGFII and IIE(68-88) peptide: a case study
  37. The added value of automated HPC count: detecting clinically important interferences on the flow cytometric CD34+ cell count
  38. Clinical pilot study on microfluidic automation of IGH-VJ library preparation for next generation sequencing
  39. Long-term effects of interventions applied to optimize the use of 25-OH vitamin D tests in primary health care
Downloaded on 4.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2023-1448/html
Scroll to top button